Literature DB >> 31833366

Biodegradable Manganese-Doped Calcium Phosphate Nanotheranostics for Traceable Cascade Reaction-Enhanced Anti-Tumor Therapy.

Lian-Hua Fu1,2, Yan-Ru Hu1, Chao Qi1, Ting He1, Shanshan Jiang1, Chao Jiang1, Jin He1, Junle Qu2, Jing Lin1, Peng Huang1.   

Abstract

Glucose oxidase (GOx) has been recognized as a "star" enzyme catalyst involved in cancer treatment in the past few years. Herein, GOx is mineralized with manganese-doped calcium phosphate (MnCaP) to form spherical nanoparticles (GOx-MnCaP NPs) by an in situ biomimetic mineralization method, followed by the loading of doxorubicin (DOX) to construct a biodegradable, biocompatible, and tumor acidity-responsive nanotheranostics for magnetic resonance imaging (MRI) and cascade reaction-enhanced cooperative cancer treatment. The GOx-driven oxidation reaction can effectively eliminate intratumoral glucose for starvation therapy, and the elevated H2O2 is then converted into highly toxic hydroxyl radicals via a Mn2+-mediated Fenton-like reaction for chemodynamic therapy (CDT). Moreover, the acidity amplification due to the gluconic acid generation will in turn accelerate the degradation of the nanoplatform and promote the Mn2+-H2O2 reaction for enhanced CDT. Meanwhile, the released Mn2+ ions can be used for MRI to monitor the treatment process. After carrying the anticancer drug, the DOX-loaded GOx-MnCaP can integrate starvation therapy, Mn2+-mediated CDT, and DOX-induced chemotherapy together, which showed greatly improved therapeutic efficacy than each monotherapy. Such an orchestrated cooperative cancer therapy demonstrated high-efficiency tumor suppression on 4T1 tumor-bearing mice with minimal side effects. Our findings suggested that the DOX-loaded GOx-MnCaP nanotheranostics with excellent biodegradability and biocompatibility hold clinical translation potential for cancer management.

Entities:  

Keywords:  Fenton reaction; biomineralization; calcium phosphate nanotheranostics; cancer therapy; glucose oxidase

Year:  2019        PMID: 31833366     DOI: 10.1021/acsnano.9b05836

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  28 in total

Review 1.  Glucose Metabolism Intervention-Facilitated Nanomedicine Therapy.

Authors:  Zhiyan Li; Xianghui Li; Shichao Ai; Song Liu; Wenxian Guan
Journal:  Int J Nanomedicine       Date:  2022-06-17

2.  Carrier-free nanoprodrug for p53-mutated tumor therapy via concurrent delivery of zinc-manganese dual ions and ROS.

Authors:  Jinping Wang; Chang Qu; Xinyue Shao; Guoqiang Song; Jingyu Sun; Donghong Shi; Ran Jia; Hailong An; Hongjun Wang
Journal:  Bioact Mater       Date:  2022-06-18

3.  Synthetic biology-instructed transdermal microneedle patch for traceable photodynamic therapy.

Authors:  Gang He; Yashi Li; Muhammad Rizwan Younis; Lian-Hua Fu; Ting He; Shan Lei; Jing Lin; Peng Huang
Journal:  Nat Commun       Date:  2022-10-20       Impact factor: 17.694

4.  Tumor cell-activated "Sustainable ROS Generator" with homogeneous intratumoral distribution property for improved anti-tumor therapy.

Authors:  Junjie Liu; Xiu Zhao; Weimin Nie; Yue Yang; Chengcheng Wu; Wei Liu; Kaixiang Zhang; Zhenzhong Zhang; Jinjin Shi
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

Review 5.  Metal peroxides for cancer treatment.

Authors:  Jin He; Lian-Hua Fu; Chao Qi; Jing Lin; Peng Huang
Journal:  Bioact Mater       Date:  2021-02-13

Review 6.  Ion Interference Therapy of Tumors Based on Inorganic Nanoparticles.

Authors:  Yongjie Chi; Peng Sun; Yuan Gao; Jing Zhang; Lianyan Wang
Journal:  Biosensors (Basel)       Date:  2022-02-06

7.  Liposome-Coated Arsenic-Manganese Complex for Magnetic Resonance Imaging-Guided Synergistic Therapy Against Carcinoma.

Authors:  Zhexiu Jin; Xue Yi; Jingjing Yang; Meili Zhou; Peifu Wu; Gen Yan
Journal:  Int J Nanomedicine       Date:  2021-06-01

Review 8.  Chemodynamic nanomaterials for cancer theranostics.

Authors:  Jingqi Xin; Caiting Deng; Omer Aras; Mengjiao Zhou; Chunsheng Wu; Feifei An
Journal:  J Nanobiotechnology       Date:  2021-06-28       Impact factor: 10.435

9.  Cell membrane inspired nano-shell enabling long-acting Glucose Oxidase for Melanoma starvation therapy via microneedles-based percutaneous delivery.

Authors:  Yang Zeng; Haiyan Zhou; Jinsong Ding; Wenhu Zhou
Journal:  Theranostics       Date:  2021-07-13       Impact factor: 11.556

10.  Advanced Cancer Starvation Therapy by Simultaneous Deprivation of Lactate and Glucose Using a MOF Nanoplatform.

Authors:  Jiantao Yu; Zixiang Wei; Qing Li; Feiyan Wan; Zhicong Chao; Xindan Zhang; Li Lin; Hong Meng; Leilei Tian
Journal:  Adv Sci (Weinh)       Date:  2021-08-07       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.